FI851837L - Foerfarande foer framstaellning av nya kompositioner. - Google Patents
Foerfarande foer framstaellning av nya kompositioner.Info
- Publication number
- FI851837L FI851837L FI851837A FI851837A FI851837L FI 851837 L FI851837 L FI 851837L FI 851837 A FI851837 A FI 851837A FI 851837 A FI851837 A FI 851837A FI 851837 L FI851837 L FI 851837L
- Authority
- FI
- Finland
- Prior art keywords
- kompositioner
- nya
- foerfarande foer
- foer framstaellning
- framstaellning
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB848412184A GB8412184D0 (en) | 1984-05-12 | 1984-05-12 | Biologically active nitrogen heterocycles |
| GB858500417A GB8500417D0 (en) | 1985-01-08 | 1985-01-08 | Biologically active nitrogen heterocycles |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| FI851837A0 FI851837A0 (fi) | 1985-05-09 |
| FI851837A7 FI851837A7 (fi) | 1985-11-13 |
| FI851837L true FI851837L (fi) | 1985-11-13 |
Family
ID=26287736
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI851837A FI851837L (fi) | 1984-05-12 | 1985-05-09 | Foerfarande foer framstaellning av nya kompositioner. |
Country Status (9)
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4711888A (en) * | 1985-07-24 | 1987-12-08 | Pfizer Inc. | Hydroxy and alkoxy pyrimidines |
| SG47583A1 (en) * | 1986-01-13 | 1998-04-17 | American Cyanamid Co | 4,5,6-Substituted-n- (substituted-phenyl) -2- pyrimidinamines |
| GB8903592D0 (en) * | 1989-02-16 | 1989-04-05 | Boots Co Plc | Therapeutic agents |
| US5064963A (en) * | 1990-04-25 | 1991-11-12 | American Cyanamid Company | Process for the synthesis of n-(3-(1h-imidazol-1-yl)phenyl-4-(substituted)-2-pyrimidinamines |
| US5248682A (en) * | 1991-01-31 | 1993-09-28 | Warner-Lambert Company | 2-substituted-4,6-di-tertiary-butyl-5-hydroxy-1,3-pyrimidines useful as antiinflammatory agents |
| US5177079A (en) * | 1991-01-31 | 1993-01-05 | Warner-Lambert Company | 2-substituted-4,6-di-tertiarybutyl-5-hydroxy-1,3-pyrimidines useful as antiinflammatory agents |
| WO1992013844A1 (en) * | 1991-01-31 | 1992-08-20 | Warner-Lambert Company | Substituted 4,6-di-tertiary-butyl-5-hydroxy-pyrimidines |
| US5270319A (en) * | 1991-09-09 | 1993-12-14 | Warner-Lambert Company | 5-hydroxy-2-pyrimidinylmethylene derivatives useful as antiinflammatory agents |
| US5220025A (en) * | 1992-02-24 | 1993-06-15 | Warner-Lambert Company | 2-substituted amino-4, 6-di-tertiary-butyl-5-hydroxy-1, 3-pyrimidines as antiinflammatory agents |
| US5196431A (en) * | 1992-02-24 | 1993-03-23 | Warner-Lambert Company | 2-substituted amino-4, 6-di-tertiary-buthyl-5-hydroxy-1, 3-pyrimidines as antiinflammatory agents |
| US5276186A (en) | 1992-03-11 | 1994-01-04 | Ciba-Geigy Corporation | Process for the production of guanidine derivatives |
| US5521184A (en) * | 1992-04-03 | 1996-05-28 | Ciba-Geigy Corporation | Pyrimidine derivatives and processes for the preparation thereof |
| US5516775A (en) * | 1992-08-31 | 1996-05-14 | Ciba-Geigy Corporation | Further use of pyrimidine derivatives |
| ATE208772T1 (de) * | 1993-10-01 | 2001-11-15 | Novartis Erfind Verwalt Gmbh | Pharmacologisch wirksame pyridinderivate und verfahren zu deren herstellung |
| US5543520A (en) * | 1993-10-01 | 1996-08-06 | Ciba-Geigy Corporation | Pyrimidine derivatives |
| WO1995009847A1 (en) * | 1993-10-01 | 1995-04-13 | Ciba-Geigy Ag | Pyrimidineamine derivatives and processes for the preparation thereof |
| WO1997033883A1 (en) | 1996-03-13 | 1997-09-18 | Smithkline Beecham Corporation | Novel pyrimidine compounds useful in treating cytokine mediated diseases |
| US6184226B1 (en) | 1998-08-28 | 2001-02-06 | Scios Inc. | Quinazoline derivatives as inhibitors of P-38 α |
| NZ521068A (en) | 2000-03-29 | 2005-04-29 | Cyclacel Ltd | 2-substituted 4-heteroaryl-pyrimidines and their use in the treatment of proliferative disorders |
| DK1442024T3 (da) * | 2001-11-01 | 2008-06-30 | Janssen Pharmaceutica Nv | Aminobenzamidderivater som glycogensystasekinase 3 beta-inhibitorer |
| EA010859B1 (ru) | 2001-11-01 | 2008-12-30 | Янссен Фармацевтика Н.В. | Гетероариламины - производные пиримидина и пиридазина в качестве ингибиторов гликогенсинтаза-киназы 3-бета (ингибиторов gsk3) |
| TW200302728A (en) | 2002-02-01 | 2003-08-16 | Novartis Ag | Substituted amines as IgE inhibitors |
| JP2007500179A (ja) | 2003-07-30 | 2007-01-11 | サイクラセル・リミテッド | キナーゼ阻害剤としての２−アミノフェニル−４−フェニルピリミジン |
| US7897607B2 (en) | 2004-04-07 | 2011-03-01 | Takeda Pharmaceutical Company Limited | Cyclic compounds |
| PL1799230T3 (pl) | 2004-08-27 | 2013-05-31 | Cyclacel Ltd | Purynowe i pirymidynowe inhibitory CDK i ich zastosowanie do leczenia chorób autoimmunologicznych |
| BRPI0616575A2 (pt) | 2005-09-27 | 2011-06-21 | Irm Llc | compostos e composições contendo diarilamina, seu uso como moduladores de receptores de c-kit bem como método para sua produção |
| GB0606774D0 (en) * | 2006-04-03 | 2006-05-10 | Novartis Ag | Organic compounds |
| CN101687853A (zh) | 2007-05-04 | 2010-03-31 | Irm责任有限公司 | 作为c-kit和pdgfr激酶抑制剂的嘧啶衍生物和组合物 |
| ATE520682T1 (de) | 2007-08-22 | 2011-09-15 | Irm Llc | 2-heteroarylaminopyrimidinderivate als kinaseinhibitoren |
| MX2010002004A (es) * | 2007-08-22 | 2010-03-11 | Irm Llc | Compuestos de 5-(4-(halo-alcoxi)-fenil)-pirimidin-2-amina y composiciones con inhibidores de cinasa. |
| EP2299823A1 (en) * | 2008-05-19 | 2011-03-30 | The University of Tennessee Research Foundation | Pyrimidine non-classical cannabinoid compounds and related methods of use |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3496179A (en) * | 1967-10-11 | 1970-02-17 | Pfizer & Co C | 2-amino-3,4-dihydroquinazolines |
| US3663706A (en) * | 1969-09-29 | 1972-05-16 | Pfizer | Use of 2,4-diaminoquinazolines as hypotensive agents |
| ZA706704B (en) * | 1969-10-16 | 1972-05-31 | Lilly Co Eli | Immunosuppresants and anti-viral agents |
| US3900476A (en) * | 1973-05-17 | 1975-08-19 | Upjohn Co | 2(2'-pyrimidylamino)quinazolines and their preparation |
| US4010269A (en) * | 1975-06-16 | 1977-03-01 | The Upjohn Company | Antiviral quinazoline compositions and methods of use |
| DE3220118A1 (de) * | 1982-05-28 | 1983-12-01 | Bayer Ag, 5090 Leverkusen | Alkylenverbrueckte guanidinothiazolderivate, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel |
-
1985
- 1985-04-25 EP EP85302902A patent/EP0164204A1/en not_active Withdrawn
- 1985-05-08 DK DK203985A patent/DK203985A/da not_active Application Discontinuation
- 1985-05-09 FI FI851837A patent/FI851837L/fi not_active Application Discontinuation
- 1985-05-09 IL IL75147A patent/IL75147A0/xx unknown
- 1985-05-09 GR GR851131A patent/GR851131B/el unknown
- 1985-05-10 PT PT80432A patent/PT80432B/pt unknown
- 1985-05-10 ES ES543047A patent/ES8609275A1/es not_active Expired
- 1985-05-10 AU AU42276/85A patent/AU4227685A/en not_active Abandoned
- 1985-05-10 NO NO851877A patent/NO851877L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| FI851837A0 (fi) | 1985-05-09 |
| EP0164204A1 (en) | 1985-12-11 |
| PT80432A (en) | 1985-06-01 |
| ES543047A0 (es) | 1986-07-16 |
| AU4227685A (en) | 1985-11-14 |
| GR851131B (c_deeref_Disk_and_Scratch_Disk_Pools_and_Their_Defaults.html) | 1985-11-25 |
| ES8609275A1 (es) | 1986-07-16 |
| FI851837A7 (fi) | 1985-11-13 |
| DK203985D0 (da) | 1985-05-08 |
| IL75147A0 (en) | 1985-09-29 |
| NO851877L (no) | 1985-11-13 |
| PT80432B (en) | 1987-04-16 |
| DK203985A (da) | 1985-11-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI855118L (fi) | Foerfarande foer framstaellning av nya peptid-aldehyder. | |
| FI852515L (fi) | Foerfarande foer framstaellning av nya gangliosidderivat. | |
| FI80883B (fi) | Foerfarande foer framstaellning av nya terapeutiskt anvaendbara bensotiazol- och bensotiofenderivat. | |
| FI851837A0 (fi) | Foerfarande foer framstaellning av nya kompositioner. | |
| FI854434A0 (fi) | Nya 5-amino-4-hydroxivaleryl-derivat. | |
| FI853336L (fi) | Nya medelst heterocyklisk acylgrupp substituerade aminoetrar. | |
| FI852694L (fi) | Nya isoindolinyl-alkyl-piperaziner. | |
| FI850130A0 (fi) | Nya 8 -asylaminoergoliner. | |
| FI862519A0 (fi) | Foerfarande foer framstaellning av nya terapeutiskt anvaendbara kinolonderivat. | |
| FI853181L (fi) | Nya 6-substituerade mitomycinderivat. | |
| FI854298L (fi) | Framstaellningsfoerfarande av nya tienopyridinderivat. | |
| FI862400L (fi) | Foerfarande foer framstaellning av nya isatinkompositioner. | |
| FI861681A7 (fi) | Foerfarande foer framstaellning av nya 4-fenylpropyl-indolderivat. | |
| FI862174A7 (fi) | Foerfarande foer framstaellning av nya terapeutiskt anvaendbara berbanderivat. | |
| FI854088L (fi) | Foerfarande foer framstaellning av nya pyridinderivat. | |
| FI855158A0 (fi) | Nya allylaminer. | |
| FI862184A7 (fi) | Foerfarande foer framstaellning av nya fenolderivat. | |
| FI853535L (fi) | Foerfarande foer framstaellning av nya bensazolderivat. | |
| FI853415A0 (fi) | Framstaellning foer nya diarylfoereningar. | |
| FI861414A0 (fi) | Foerfarande foer framstaellning av nya bensoesyraderivat. | |
| FI851774A0 (fi) | Foerfarande foer framstaellning av nya kinolinderivat. | |
| FI841292A0 (fi) | Nya timololmellanprodukter. | |
| FI853005L (fi) | Nya aminoalkylpenem-foereningar. | |
| FI851577L (fi) | Foerfarande foer framstaellning av nya pyranoderivat. | |
| FI854788L (fi) | Nya 13 -alkyl-17 - (3-acyloxipropyl)-gonaner. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD | Application lapsed |
Owner name: FISONS PLC |